Suso J Platero

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.

J. Tabernero, A. Italiano, J. Soria, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.